Open an account

National Graphite

NGRC · OTC

$0.0273−$0.0017 (−5.86%)TodayMarket closed ·
Prev close $0.029

About NGRC

National Graphite Corp. is an exploration company, which engages in the exploration of gold, silver, and related minerals. The company is headquartered in Dusseldorf, Nordrhein-Westfalen. The company went IPO on 2009-06-30. The firm is pursuing the commercial development of a drug candidate, elafin, for the treatment of postoperative inflammatory complications. Elafin is a human identic protein. The firm operates in Germany, in collaboration with clinical-stage companies that develop new biological entities or new therapeutically platforms in the treatment for various diseases, rare diseases and diseases with unmet needs. Biotech Development Corp. is the Company's subsidiary. As of February 28, 2015, the Company had not generated any revenues.

Employees
1
Headquarters
Dusseldorf, Nordrhein-Westfalen
Listed
Jun 30, 2009
Sector
Health Care
Industry
Biotechnology

NGRC key statistics

Market cap
4.21M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
13.10K
Volume
99
Open price
$0.0221
High today
$0.0307
Low today
$0.0221
52 Week high
$0.0482
52 Week low
$0.0142

National Graphite (NGRC) at a glance

As of Oct 20, 2026, National Graphite (NGRC) shares are priced at $0.0273, giving the company a market cap of 4.21M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.0221 and $0.0307. The current price is 23.5% above the day's low and 11.1% below its high.

Volume so far is 99 shares, below the average of 13.10K shares a day.

Over the past year National Graphite has ranged from $0.0142 to $0.0482, and now sits 39% of the way up that range.

Similar companies

Companies in the same industry as National Graphite

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.